MNTA - Momenta Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue138,882109,61989,650
Cost of Revenue---
Gross Profit138,882109,61989,650
Operating Expenses
Research Development149,226119,880126,033
Selling General and Administrative82,20764,46648,051
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-92,551-74,727-84,434
Income from Continuing Operations
Total Other Income/Expenses Net4,45553,7241,121
Earnings Before Interest and Taxes-88,096-21,003-83,313
Interest Expense---
Income Before Tax-88,096-21,003-83,313
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-88,096-21,003-83,313
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-88,096-21,003-83,313
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-88,096-21,003-83,313